State Drug Administration Department pushes for price control of heart and kidney medicines

The State Drug Administration Department is pushing the central government for price control on medicines for heart and kidney diseases. They are preparing a list of expensive drugs used for treating these chronic conditions. This effort aims to reduce the financial burden on patients who require long-term medication.